Empowering People Hurt by Big Businesses

Local (415) 319-8833
Toll Free (855) 534-0061

Blog Posts in August, 2012

  • GSK PAYS $3 BILLION SETTLEMENT FOR ILLEGAL PHARMACEUTICAL MARKETING

    In our last post, we discussed a $3 billion settlement agreed to by drugmaker GlaxoSmithKline to settle allegations that it illegally marketed dangerous pharmaceuticals for unapproved, off-label uses. In addition to the antidepressant Paxil, authorities allege that the drugmaker mismarketed several other drugs, including Wellbutrin and Avandia. Wellbutrin, also known as bupropion, is used to treat ...
    Continue Reading
  • GLAXOSMITHKLINE ADMITS TO IMPROPERLY MARKETING PAXIL

    British pharmaceutical giant GlaxoSmithKline (GSK) recently agreed to pay a record-breaking $3 billion settlement for the improper marketing of many dangerous pharmaceuticals, including Paxil. Federal regulators say that the drugmaker marketed several of its drugs for unapproved, off-label uses. This type of marketing is common among large drugmakers and is unlikely to stop despite massive fines ...
    Continue Reading
Page 1 of 1